Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 11 | $18,315,122 |
Sells | 0 | $0 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
22 Aug 2022 08:30 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 19 Aug 2022 | Purchase | 6,060 | 108.8 | 659,328 | D |
22 Aug 2022 08:30 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 19 Aug 2022 | Purchase | 40,110 | 108.2 | 4,339,902 | D |
15 Sep 2022 08:00 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 14 Sep 2022 | Purchase | 6,250 | 105.16 | 657,250 | D |
15 Sep 2022 08:00 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 14 Sep 2022 | Purchase | 30,106 | 104.67 | 3,151,195 | D |
15 Sep 2022 08:00 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 14 Sep 2022 | Purchase | 20,744 | 103.87 | 2,154,679 | D |
11 Aug 2023 07:40 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 10 Aug 2023 | Purchase | 1,091 | 105.9 | 115,537 | I |
11 Aug 2023 07:40 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 10 Aug 2023 | Purchase | 31,570 | 106.26 | 3,354,628 | I |
11 Aug 2023 07:40 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 10 Aug 2023 | Purchase | 2,206 | 104.67 | 230,902 | I |
14 Aug 2023 08:00 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 11 Aug 2023 | Purchase | 23,686 | 108.05 | 2,559,272 | I |
15 Aug 2023 08:00 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 14 Aug 2023 | Purchase | 4,032 | 109.89 | 443,076 | I |
15 Aug 2023 08:00 | SRPT | Sarepta Therapeutics Inc | CHAMBERS MICHAEL ANDREW | Director | 14 Aug 2023 | Purchase | 5,947 | 109.19 | 649,353 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)